{
    "name": "poly-L-lactic acid/carboxymethylcellulose/mannitol",
    "comment": "Rx",
    "other_names": [
        "Sculptra Aesthetic"
    ],
    "classes": [
        "Aesthetic Surgery Products"
    ],
    "source": "https://reference.medscape.com/drug/sculptra-aesthetic-poly-l-lactic-acid-carboxymethylcellulose-mannitol-999827",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: Unknown whether distributed in breast milk"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Unknown whether distributed in breast milk"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to components",
                "Known history of or susceptibility to keloid formation"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Unique injection requirements which include tunneling technique in grid pattern; use only by physician trained with technique",
                "Do not overcorrect contour deficiency; facial depression expected to gradually improve over several weeks",
                "Do not inject in blood vessels; may cause vacular occlusion, infarction, or emboli",
                "Defer injection if treatment area is inflamed (eg, cysts, pimples, rash, hives) or infected",
                "Injection site reactions include delayed occurrence of papules, nodules, hematoma, bruising-ecchymosis, bleeding, edema, discomfort, inflammation, and erythema",
                "Safety and efficacy has not been established for use in the lips, periorbital area, during pregnancy or lactation, or in individuals with history of keloid formation, hypertrophic scarring, connective tissue disease, active inflammatory conditions, bleeding disorders, active hepatitis, serious abnormalities in lab findings (eg, cancer, stroke, MI), on any immunosuppressive therapy, and/or with any other prior or concomitant treatment at the treatment site",
                "The microparticles may be visible on CT scans, MRI, or by other imaging techniques"
            ],
            "specific": [
                {
                    "type": "Embolization",
                    "description": [
                        "Rare, but serious, injuries may occur as a result of unintentional injection of a soft tissue filler into blood vessels in the face",
                        "May result in restricted blood supply to tissues and lead to embolization, which could cause vision impairment, blindness, stroke, and damage and/or necrosis of the skin and underlying facial structures"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Injection site pain",
            "percent": "9.5"
        },
        {
            "name": "Injection site nodule",
            "percent": "8.6"
        },
        {
            "name": "Injection site papule",
            "percent": "8.6"
        },
        {
            "name": "Nasopharyngitis",
            "percent": "6"
        },
        {
            "name": "Headache",
            "percent": "4.3"
        },
        {
            "name": "Injection site erythema",
            "percent": "3.4"
        },
        {
            "name": "Acne",
            "percent": "2.6"
        },
        {
            "name": "Pain",
            "percent": "2.6"
        },
        {
            "name": "Injection site hemorrhage",
            "percent": "1.7"
        },
        {
            "name": "Swelling",
            "percent": "1.7"
        },
        {
            "name": "Allergic reaction",
            "percent": null
        },
        {
            "name": "Angioedema",
            "percent": null
        },
        {
            "name": "Hypertrophy of skin",
            "percent": null
        },
        {
            "name": "Injection site discharge",
            "percent": null
        },
        {
            "name": "abscess",
            "percent": null
        },
        {
            "name": "atrophy",
            "percent": null
        },
        {
            "name": "granuloma",
            "percent": null
        },
        {
            "name": "and induration",
            "percent": null
        }
    ]
}